Loading ...
Loading ...
Loading ...
Appendix 125
actions, the FDA has urged the wireless phone industry to take a number
of steps, including the following:
Ţ Support needed research into possible biological effects of RF of the
type emitted by wireless phones;
Ţ Design wireless phones in a way that minimizes any RF exposure to
the user that is not necessary for device function; and
Ţ Cooperate in providing users of wireless phones with the best possible
information on possible effects of wireless phone use on human
health.
The FDA belongs to an interagency working group of the federal
agencies that have responsibility for different aspects of RF safety to
ensure coordinated efforts at the federal level. The following agencies
belong to this working group:
Ţ National Institute for Occupational Safety and Health
Ţ Environmental Protection Agency
Ţ Occupational Safety and Health Administration
Ţ National Telecommunications and Information Administration
The National
Institutes of Health participates in some interagency
working group activities, as well.
The FDA shares regulatory responsibilities for wireless phones with the
Federal Communications Commission (FCC). All phones that are sold in
the United States must comply with FCC safety guidelines that limit RF
exposure. The FCC relies on the FDA and other health agencies for safety
questions about wireless phones.
The FCC also regulates the base stations that the wireless phone
networks rely upon. While these base stations operate at higher power
than do the wireless phones themselves, the RF exposures that people
get from these base stations are typically thousands of times lower than
those they can get from wireless phones. Base stations are thus not the
subject of the safety questions discussed in this document.
Loading ...
Loading ...
Loading ...